Source: Pharma Manufacturing
More...
FDA approves Progenics’ drug for rare tumors
The drug, Azedra, was approved to treat patients above the age of 12 who have either of the two tumors, pheochromocytoma or paraganglioma, and require anti-cancer therapy
